Prediction of cardiovascular events by matrix metalloproteinase (MMP)-9 in elderly men

Thrombosis and Haemostasis

Volumn 103, Issue 3, 2010, Pages 679-681

  Weiss, Thomas W ^a,b,c   Furenes, Eline B ^a   Trøseid, Marius ^a   Solheim, Svein ^a   Hjerkinn, Elsa M ^a   Seljeflot, Ingebjorg ^a,c   Arnesen, Harald ^a,c  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b WILHELMINEN HOSPITAL   (Austria)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GELATINASE B; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

AORTA ANEURYSM; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; DIASTOLIC BLOOD PRESSURE; HEART INFARCTION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LETTER; NON INSULIN DEPENDENT DIABETES MELLITUS; PERCUTANEOUS CORONARY INTERVENTION; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE;

AGED; CARDIOVASCULAR DISEASES; HUMANS; LIPOPROTEINS; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; PREDICTIVE VALUE OF TESTS;

EID: 77749298277     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH09-05-0317     Document Type: Letter

References (12)

1. Ikeda U, Shimada K. Matrix metalloproteinases and coronary artery diseases. Clin Cardiol 2003; 26: 55-59.
2. Newby AC, George SJ, Ismail Y, et al. Vulnerable atherosclerotic plaque metalloproteinases and foam cell phenotypes. Thromb Haemost 2009; 101: 1006-1011.
3. Cicero AF, Derosa G, Manca M, et al. Vascular remodeling and prothrombotic markers in subjects affected by familial combined hyperlipidemia and/or metabolic syndrome in primary prevention for cardiovascular disease. Endothelium 2007; 14: 193-198.
4. Derosa G, D'Angelo A, Ciccarelli L, et al. Matrix metalloproteinase-2, -9, and tissue inhibitor of metalloproteinase-1 in patients with hypertension. Endothelium 2006; 13: 227-231.
5. Derosa G, D'Angelo A, Tinelli C, et al. Evaluation of metalloproteinase 2 and 9 levels and their inhibitors in diabetic and healthy subjects. Diabetes Metab 2007; 33: 129-134.
6. El Messal M, Beaudeux JL, Drissi A, et al. Elevated serum levels of proinflammatory cytokines and biomarkers of matrix remodeling in never-treated patients with familial hypercholesterolemia. Clin Chim Acta 2006; 366: 185-189.
7. Hjerkinn EM, Abdelnoor M, Breivik L, et al. Effect of diet or very long chain omega-3 fatty acids on progression of atherosclerosis, evaluated by carotid plaques, intima-media thickness and by pulse wave propagation in elderly men with hypercholesterolaemia. Eur J Cardiovasc Prev Rehabil 2006; 13: 325-333.
8. Furenes EB, Seljeflot I, Solheim S, et al. Long-term influence of diet and/or omega-3 fatty acids on matrix metalloproteinase-9 and pregnancy-associated plasma protein-A in men at high risk of coronary heart disease. Scand J Clin Lab Invest 2008; 68: 177-184.
9. Bermudez B, Lopez S, Pacheco YM, et al. Influence of postprandial triglyceride-rich lipoproteins on lipid-mediated gene expression in smooth muscle cells of the human coronary artery. Cardiovasc Res 2008; 79: 294-303.
10. Chakrabarti S, Patel KD. Regulation of matrix metalloproteinase-9 release from IL-8-stimulated human neutrophils. J Leukoc Biol 2005; 78: 279-288.
11. Ruhul Amin AR, Senga T, Oo ML, et al. Secretion of matrix metalloproteinase-9 by the proinflammatory cytokine, IL-1beta: a role for the dual signalling pathways, Akt and Erk. Genes Cells 2003; 8: 515-523.
12. Lijnen HR. Plasmin and matrix metalloproteinases in vascular remodeling. Thromb Haemost 2001; 86: 324-333.